CRIMI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 1.911
AS - Asia 985
EU - Europa 818
SA - Sud America 199
AF - Africa 154
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.070
Nazione #
US - Stati Uniti d'America 1.895
SG - Singapore 757
IT - Italia 399
IE - Irlanda 232
BR - Brasile 183
CN - Cina 144
CI - Costa d'Avorio 96
RU - Federazione Russa 42
SN - Senegal 42
FI - Finlandia 29
IN - India 28
DE - Germania 24
UA - Ucraina 22
NL - Olanda 19
CA - Canada 14
NG - Nigeria 12
GB - Regno Unito 11
SE - Svezia 11
VN - Vietnam 9
TR - Turchia 8
AT - Austria 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
FR - Francia 5
IQ - Iraq 5
PK - Pakistan 5
ES - Italia 4
AR - Argentina 3
BE - Belgio 3
EC - Ecuador 3
HK - Hong Kong 3
JP - Giappone 3
VE - Venezuela 3
EU - Europa 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
MX - Messico 2
NP - Nepal 2
PH - Filippine 2
PL - Polonia 2
RO - Romania 2
TW - Taiwan 2
BD - Bangladesh 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
LT - Lituania 1
MA - Marocco 1
MC - Monaco 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 4.070
Città #
Santa Clara 752
Singapore 482
Dublin 232
Chicago 187
Boardman 176
Chandler 100
Abidjan 96
Ashburn 83
Catania 67
Civitanova Marche 66
Dakar 42
Milan 39
Los Angeles 35
Jacksonville 33
Lappeenranta 24
Pune 23
Lawrence 19
São Paulo 19
Andover 18
Cambridge 18
Seattle 18
Des Moines 14
Nanjing 13
Abuja 12
Toronto 12
Council Bluffs 11
Palermo 10
Bremen 9
Dong Ket 9
Giarre 9
Reggio Emilia 8
Wilmington 8
Rome 7
Shenyang 7
Amsterdam 6
Assago 6
Corbetta 6
Gravina di Catania 6
Munich 6
Naples 6
Phoenix 6
Abbiategrasso 5
Beijing 5
Brasília 5
Helsinki 5
Mumbai 5
Nanchang 5
Rio de Janeiro 5
Grafing 4
Madrid 4
Mascali 4
New York 4
Rimini 4
Salvador 4
Belo Horizonte 3
Brussels 3
Cesa 3
Dordrecht 3
Fortaleza 3
Gravina in Puglia 3
Hebei 3
Istanbul 3
Mascalucia 3
Messina 3
Paris 3
Pogliano Milanese 3
Praia Grande 3
Saint Petersburg 3
San Mateo 3
Taizhou 3
Tianjin 3
Tokyo 3
Zhengzhou 3
Aci Catena 2
Alessandria 2
Aracaju 2
Araras 2
Astoria 2
Bitonto 2
Bogotá 2
Bruneck 2
Cagliari 2
Campinas 2
Casale Monferrato 2
Changsha 2
Corato 2
Curitiba 2
Erbil 2
Genoa 2
Giulianova 2
Hengyang 2
Innsbruck 2
Lahore 2
Laives 2
Legnano 2
Ottawa 2
Ourinhos 2
Partinico 2
Pearl City 2
Perugia 2
Totale 2.870
Nome #
Bronchodilator response as a marker of poor asthma control 74
Protective effect of Resveratrol on TGF-beta-induced lung fibroblast differentiation 73
Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer 73
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients 69
Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction 68
Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells 66
Prevalence and determinants of co-morbidities in patients with obstructive apnea and chronic obstructive pulmonary disease 66
Mutual Interaction Between Human Lung Fibroblasts And T LymphocyteS 65
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 65
Rugarli. Medicina interna sistematica 63
Exhaled breath condensate cysteinyl leukotrienes (cys-LTs) in gastroesophageal reflux disease-related asthma 62
Reliability and usefulness of a rapid IgM‐IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report 62
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics 59
Point-of-care blood eosinophil count in a severe asthma clinic setting 53
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 48
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 47
Resumption of respiratory outpatient services in the COVID-19 era: Experience from Southern Italy 47
Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies 45
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux 45
Is the Power Spectrum of Electromyography Signal a Feasible Tool to Estimate Muscle Fiber Composition in Patients with COPD? 45
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 44
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 44
Bronchial reversibility testing: an index of poorly controlled asthma 43
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 42
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 42
Impact of chronic obstructive pulmonary disease on passive viscoelastic components of the musculoarticular system 42
Tezepelumab for asthma 41
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 38
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 37
Impact of asthma on bronchiectasis severity and risk of exacerbations 37
Prolonged respiratory failure: when doctor and family connect, the patient wins 35
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 35
Intermittent abdominal pressure ventilation management in neuromuscular diseases: a Delphi panel Consensus 33
Adherence to omalizumab: A multicenter "real-world" study 33
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression 33
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 33
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 32
Diastolic Function and Positive Airway Pressure: More Research Is Warranted 32
Diagnostic delay in bronchiectasis: an Italian perspective 32
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 32
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 31
Airway hyperresponsiveness with chest strapping: A matter of heterogeneity or reduced lung volume? 31
European survey of domiciliary noninvasive ventilation (NIV) in severe COPD patients: the Italian practices 31
Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma 30
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 30
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 30
A new gambler at the table of management of COVID-19 associated acute respiratory failure. Changing position to do it better? 30
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis 29
Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study 29
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 28
Comparability of asthma control test scores between self and physician-administered test 28
Anti-inflammatory role of vitamin D in muscle dysfunctions of patients with chronic obstructive pulmonary disease: a comprehensive review 28
High Level of Blood Eosinophils and Localization of Bronchiectasis in Patients with Severe Asthma: A Pilot Study 28
Secretion management in patients with ineffective airway clearance with non-invasive mechanical ventilation use: Expert guidance for clinical practice 27
Asthma severity: the patient’s point of view 27
A Key to Unlocking the Mysteries of COVID-19 Pulmonary Sequelae: Are We There? 27
Performance of EasyBreath Decathlon Snorkeling mask for delivering continuous positive airway pressure 27
Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections 27
The influence of policies limiting author self-citations on journals impact factor and self-citation rate in respiratory system 27
Bronchiectasis and asthma: a dangerous liaison? 27
Personalized Medicine in Asthma: Current Approach and Future Perspectives 26
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the mask 26
Domiciliary Non-invasive Ventilation in COPD: An International Survey of Indications and Practices 26
Long-term home noninvasive ventilation (LTHNIV) in restrictive thoracic diseases: The Italian snapshot 26
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 26
Home High Flow Nasal Therapy for Patients at End of Life: Benefits, Hopes, and Goals of Care 26
REINVENT: ERS International survey on REstrictive thoracic diseases IN long term home noninvasive VENTilation 25
Are we overlooking the lung function in the definition of severe asthma remission? 25
Novel Biological Therapies for Severe Asthma Endotypes 25
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 25
Noninvasive Ventilation for Weaning and Post-Extubation Failure 25
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers 25
Biologics in severe asthma 25
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial 25
Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use 25
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 25
The clinical significance of delirium in the intensive care unit 25
Effects of high-flow nasal therapy on swallowing function: a scoping review 24
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma 24
Continuous vs intermittent Non-Invasive blood pressure MONitoring in preventing postoperative organ failure (niMON): study protocol for an open-label, multicenter randomized trial 24
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 24
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 24
Switching Biological Therapies in Severe Asthma 24
A pragmatic, open-label, multi-center, randomized controlled clinical trial on the rotational use of interfaces vs standard of care in patients treated with noninvasive positive pressure ventilation for acute hypercapnic respiratory failure: the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) 24
Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate 23
A European survey of Non- Invasive Ventilation (NIV) 23
Ultrasound-guided placement of long peripheral cannula in children with cystic fibrosis 23
High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future 23
Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma 23
Determinants of tracheostomy decannulation: an international survey 23
Fully covered self-expandable metal stent (SEMS) in tracheo-bronchial disorders: clinical experience 22
Uneven use of noninvasive ventilation in acute respiratory failure in Europe 22
Airway hyperresponsiveness with chest strapping: effects of heterogeneity and reduced lung volume 22
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 22
High flow nasal therapy in Acute Exacerbation of COPD: Ready for the prime time? 22
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients 21
Effect of Laboratory Testing Guidelines on the Utilization of Tests and Order Entries in a Surgical Intensive Care Unit 21
Noninvasive continuous arterial pressure monitoring with Clearsight during awake carotid endarterectomy: A prospective observational study 21
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 21
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 21
Totale 3.459
Categoria #
all - tutte 21.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 0 0 0 0 6 2
2020/202194 0 3 11 3 19 5 9 0 7 18 9 10
2021/2022126 12 20 0 2 17 0 20 2 14 2 3 34
2022/2023635 19 11 8 44 23 50 49 115 249 19 19 29
2023/2024690 24 78 40 59 29 125 16 69 7 34 135 74
2024/20252.604 69 454 223 109 616 373 131 83 229 304 13 0
Totale 4.258